Pricing Log in Create free account

Neuraxis, Inc. (NRXS) vs PolyPid Ltd. (PYPD)

Neuraxis, Inc. and PolyPid Ltd. are both Biotechnology companies. Neuraxis, Inc. and PolyPid Ltd. are of similar size ($99.5M and $97.2M). PolyPid Ltd. has the higher net margin (0.00% vs −159.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Neuraxis, Inc. leads on 6 and PolyPid Ltd. on 5.

Valuation

Metric NRXS PYPD Biotechnology median
P/E n/m n/m 8.50
P/S 17.55 n/m 9.71
P/B 13.86 19.96 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 16.00 n/m 9.21
Earnings yield (10.13%) (31.16%) (33.15%)
Free cash flow yield (6.20%) (71.51%) (25.50%)

Profitability

Metric NRXS PYPD Biotechnology median
Gross margin 85.56% — 65.16%
Operating margin (144.51%) 0.00% 0.00%
Net margin (159.01%) 0.00% 0.00%
Free cash flow margin (106.10%) 0.00% 0.00%
Return on equity (153.96%) (243.59%) (56.36%)
Return on assets (98.96%) (119.05%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRXS PYPD Biotechnology median
Revenue growth (TTM) 65.22% — 6.02%
EPS growth (last fiscal year) 22.13% 57.43% 30.26%
Revenue growth, 5-year CAGR 13.08% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXS PYPD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.04 1.35 4.72
Net debt to EBITDA 0.64 0.39 0.96

Dividend

Metric NRXS PYPD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NRXS PYPD Biotechnology median
Market cap 97.19m 99.53m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack